Skip to main
NEOG

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Neogen Corporation's strategic focus on food and animal safety positions it favorably within a growing market, as the demand for diagnostics and safety products continues to rise in response to increasing food safety regulations and consumer awareness. The company's recent acquisition has strengthened its market position, enhancing its growth potential and operational capacity. Although Neogen faces competitive pressures and supply chain sensitivities, its commitment to innovation and expansion through internal growth and acquisitions provides a solid foundation for future financial performance.

Bears say

Neogen Corporation has experienced challenges in its financial performance, indicating potential vulnerabilities in its market position and operational efficiency. The company's sales growth has been decelerating, which raises concerns regarding its ability to maintain revenue momentum in a competitive landscape. Additionally, rising costs associated with production and supply chain disruptions have negatively impacted profitability margins, further signaling a need for careful strategic reassessment to address ongoing financial pressures.

Neogen (NEOG) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 3 analysts, Neogen (NEOG) has a Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.